Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

446 results

In hoeverre leent de WAMCA-procedure zich voor massaschadeclaims op grond van de AVG?

Binnen de massaschadepraktijk speelt al langer de vraag in hoeverre het mogelijk is om middels een WAMCA-procedure schadevergoeding te vorderen voor een vermeende inbreuk op de AVG.

Compensation after infringement of the General Data Protection Regulation: European developments

The General Data Protection Regulation (GDPR) is one of the most significant development in the European data strategy in the past years and is continuously evolving.

Een inbreuk op de AVG geeft niet zonder meer recht op schadevergoeding: Europese ontwikkelingen

De Algemene Verordening Gegevensbescherming (de “AVG”) is één van de meest ingrijpende ontwikkelingen binnen de Europese datastrategie van de afgelopen jaren en nog steeds volop in ontwikkeling.

Manon Cremers

Partner Amsterdam

Anna-Belle de Blanken

Associate London

Maarten Jorissen

Associate Amsterdam

Maurits Schmitz

Senior Associate Amsterdam

Cross-border corporate lending into the Netherlands

Cross-border corporate lending is set for change as CRD VI introduces new licensing obligations, requiring non-EU lenders to reassess their activities in the Netherlands and the EU for all in scope contracts signed on or after 11 July 2026.

Julie Joos

Junior Associate Brussels

The Netherlands Implements EU Non-Performing Loan Directive

The Dutch Implementation Act on Credit Servicers and Credit Purchasers entered into force on 18 July 2025. It implements EU Directive 2021/2167 regulating NPL sale, purchase and servicing to create a transparent secondary market.

Cristina Pasion Pereda

Junior Associate Luxembourg

Stibbe StartsUP welcomes Qaring

Stibbe is delighted to announce that Qaring is the latest start-up to join the Stibbe StartsUp program.

Carole Hensmans

Associate Brussels

Legal Considerations for Artificial Intelligence in the Life Sciences Sector

This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.

Pagination

  • Previous page
  • Page 22
  • Page 23
  • Page 24
  • Current page 25
Reset filters
Date
Content type
  • Article (221)
  • Event (19)
  • Inside Stibbe (11)
  • Matter (137)
  • Podcast (3)
  • People (55)
Expertise
  • (-) Capital Markets (247)
  • (-) Privacy and Data Protection (204)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (429)
  • Compliance, Sanctions and Risk (162)
  • Corporate and M&A (863)
  • Corporate Investigations (31)
  • Criminal Law and Enforcement (143)
  • Digital Economy (108)
  • Employment, Benefits and Pensions (409)
  • Energy, Industry and Climate (311)
  • Environment and Planning (881)
  • ESG & Sustainability (295)
  • EU and Competition Law (492)
  • Financial Regulation (173)
  • Healthcare and Life Sciences (86)
  • Infrastructure and Mobility (192)
  • Insurance (36)
  • Intellectual Property (121)
  • Investment Funds (141)
  • Litigation and Arbitration (426)
  • Private Equity (197)
  • Procurement Law (122)
  • Public Law (1189)
  • Real Estate (470)
  • Restructuring and Insolvency (116)
  • Sports (25)
  • Tax (444)
  • Technology, Media and Telecommunications (331)
  • Unfair Competition and Consumer Protection (186)
Jurisdiction
  • BE Law (95)
  • EU Law (128)
  • LU Law (28)
  • NL Law (244)
Language
  • Dutch (81)
  • English (361)
  • French (4)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Cookies Settings
  • Important Information